ResearcherFujian Medical UniversityNo recent work listed

Liang Zhao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1303-8775; OpenAlex author ID A5009857183. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

Fibroblast Activation Protein Inhibitor PET in Pancreatic Cancer. Co-author DOI 10.1016/j.cpet.2023.02.001 ↗
Positron emission tomography and computed tomography with [68Ga]Ga-fibroblast activation protein inhibitors improves tumor detection and staging in patients wi… Co-author DOI 10.1007/s00259-021-05576-w ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yizhen Pang · 2 shared papers, 2022–2023 · strength 0.35
- Paper Fibroblast Activation Protein Inhibitor PET in Pancreatic Cancer. DOI 10.1016/j.cpet.2023.02.001 ↗
- Paper Positron emission tomography and computed tomography with [68Ga]Ga-fibroblast activation protein inhibitors improves tu… DOI 10.1007/s00259-021-05576-w ↗
Haojun Chen · 2 shared papers, 2022–2023 · strength 0.35
- Paper Fibroblast Activation Protein Inhibitor PET in Pancreatic Cancer. DOI 10.1016/j.cpet.2023.02.001 ↗
- Paper Positron emission tomography and computed tomography with [68Ga]Ga-fibroblast activation protein inhibitors improves tu… DOI 10.1007/s00259-021-05576-w ↗
Shuangjia Wang · 1 shared paper, 2022 · strength 0.13
- Paper Positron emission tomography and computed tomography with [68Ga]Ga-fibroblast activation protein inhibitors improves tu… DOI 10.1007/s00259-021-05576-w ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.